Trial intelligence / Profile preview

TAILoR trial of telmisartan for insulin resistance in adults with HIV on cART

2012-000935-18Phase 2Completed

Sponsor
University of Liverpool
Start
May 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of telmisartan in insulin resistance (IR) (2 arms), sponsored by University of Liverpool. Primary endpoint: Reduction in insulin resistance. Started May 2012; status: completed.

02

Drugs

telmisartan
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on 2012-000935-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-000935-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call